| NVUS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the NVUS shares outstanding history going back to 5/11/2017:
Also see: NVUS Market Cap History NVUS YTD Return |
NVUS Shares Outstanding History — Novus Therapeutics Share Count Over Time
As of 11/13/2020 Novus Therapeutics has 1.43 million NVUS shares outstanding. Investors often track the NVUS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NVUS share count trends over time, with 16 historical shares outstanding datapoints presented, dating back to 5/11/2017.
| NVUS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||
NVUS Historical Shares Outstanding: +93.94% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| NVUS Stock Price Chart |
| About Eledon Pharmaceuticals Inc |
| Novus Therapeutics is a pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat. Co. has two platform technologies, a surfactant and a foam. Co.'s primary program, OP0201, is a surfactant-based nasal aerosol drug-device combination product candidate being developed as a treatment option for patients at risk for, or with, otitis media (OM). OM is defined as middle ear inflammation and effusion with or without infection. Co. also has a foam-based drug delivery technology platform, which may be developed to deliver drugs into the ear, nasal, and sinus cavities. We show 16 historical shares outstanding datapoints in our coverage of NVUS's shares outstanding history. Understanding the changing numbers of NVUS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NVUS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NVUS by allowing them to research NVUS shares outstanding history as well as any other stock in our coverage universe. |
| NVUS Current Stock Quote |
Quotes delayed 20 minutes  Free NVUS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NVUS Share Performance |
| Shares Outstanding Peers |
| Novus Therapeutics (NVUS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NXGL Shares Outstanding History NXL Shares Outstanding History NXTC Shares Outstanding History NXTM Shares Outstanding History NYMX Shares Outstanding History OABI Shares Outstanding History OBIO Shares Outstanding History OBLN Shares Outstanding History OCGN Shares Outstanding History OCUL Shares Outstanding History More Healthcare companies » |
NVUS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
